"In der Klinik für Thorax- und Kardiovaskularchirurgie des Herz- und Diabeteszentrum NRW unter der Leitung von Prof. Dr. med. Jan Gummert werden jährlich 3.600 Eingriffe am Herzen und den herznahen Gefäßen durchgeführt. Die Klinik ist deutschlandweit führend in den Bereichen Herzklappenoperationen, Herztransplantationen, Kunstherzimplantationen sowie Herzschrittmacher-/ ICD-Eingriffe. Seit 1989 wurden hier mehr als 4.000 Herzunterstützungssysteme implantiert. Mit 73 Herztransplantationen in 2020 (gesamt: über 2.500) ist die Klinik das bundesweit größte Herztransplantationszentrum. Zu den weiteren Schwerpunkten der Klinik zählen die minimalinvasive Klappenchirurgie und die Bypasschirurgie am schlagenden Herzen."

During the past decade, Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "CytoSorbents, Inc" with 1 trials as a collaborator, "ENDI-Foundation, Bad Homburg, Germany" with 1 trials as a collaborator, "Fraunhofer Institute for Interfacial Engineering and Biotechnology" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" are "Dilated Cardiomyopathy" (1 trials) and "Infective Endocarditis" (1 trials). Many other conditions were trialed in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" in a lesser frequency.

Most popular intervention types in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "hemoadsorber for removal of cytokines" (1 trials), "protein A immunoadsorption" (1 trials) and "pseudo-immunoadsorption" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".